2,0
23 gen 2018
Dipendente anonimo
Dipendente attuale
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Not much on that front. I guess their severance package is half way decent.
Svantaggi
Absolutely no regard for employees of ZS Pharma after they bought the company at the end of 2015. People had many options to leave but a lot were committed to staying and seeing the product for Hyperkalemia launch, despite two CRL's. This loyalty was rewarded by deciding to close the San Mateo site and move the business to Wilmington with no sound rationale. Since the announcement, AZ has had no regard for the employees in San Mateo and have been treating them as disposable assets to be discarded after knowledge is transferred to AZ folks.